1. Home
  2. CTBI vs COLL Comparison

CTBI vs COLL Comparison

Compare CTBI & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Trust Bancorp Inc.

CTBI

Community Trust Bancorp Inc.

HOLD

Current Price

$61.90

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$32.48

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTBI
COLL
Founded
1903
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
CTBI
COLL
Price
$61.90
$32.48
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$59.50
$51.17
AVG Volume (30 Days)
77.6K
520.9K
Earning Date
04-17-2026
05-07-2026
Dividend Yield
3.44%
N/A
EPS Growth
17.79
N/A
EPS
5.43
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$14.02
$5.93
Revenue Next Year
$4.30
N/A
P/E Ratio
$11.35
$19.22
Revenue Growth
N/A
23.62
52 Week Low
$44.60
$23.23
52 Week High
$65.79
$50.79

Technical Indicators

Market Signals
Indicator
CTBI
COLL
Relative Strength Index (RSI) 58.79 29.65
Support Level $56.42 $31.01
Resistance Level $65.64 $32.92
Average True Range (ATR) 1.77 1.27
MACD 0.36 0.14
Stochastic Oscillator 94.12 11.10

Price Performance

Historical Comparison
CTBI
COLL

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and south-central Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services. The company operates in one reportable segment: community banking services.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: